Development and characterisation of a new model of rat trophoblasts

被引:3
作者
Beghin, D. [1 ,2 ,3 ]
Delongeas, J. -L. [2 ,3 ]
Claude, N. [2 ,3 ]
Forestier, F. [1 ]
Farinotti, R. [1 ,4 ]
Gil, S. [1 ]
机构
[1] Univ Paris Sud, Fac Pharm, EA 2706, IFR141, F-92296 Chatenay Malabry, France
[2] Servier Grp, Drug Safety Assessment, Gidy, France
[3] Servier Grp, Drug Safety Assessment, Paris, France
[4] Grp Hosp Pitie Salpetriere, AP HP, Serv Pharm, F-75634 Paris, France
关键词
Placenta; Primoculture and cryopreserved trophoblasts; P-Glycoprotein; Bcrp; Rat; CANCER RESISTANCE PROTEIN; LIMITS FETAL DISTRIBUTION; P-GLYCOPROTEIN; EFFLUX TRANSPORTERS; EXPRESSION; PLACENTA; BCRP/ABCG2;
D O I
10.1016/j.tiv.2008.10.007
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The placenta plays a key role during pregnancy. In vitro models have proven to assess the role of placental transporters in the exchange of nutrients,waste products and the distribution of drugs between the maternal and fetal compartments. Therefore, a primoculture of Wistar rat trophoblasts from the labyrinth zone was developed and characterised. Expression of placental transporters including P-glycoprotein (P-gp) and bcrp was evaluated by western blot and their activity using different inhibitors. A time-dependent increase in P-gp expression was noted from primocultures Day 2 to Day 4 followed by a plateau thereafter, whereas bcrp expression was stable throughout the Culture Period. P-gp and bcrp expression was maintained after seven pas,;ages in primocultures and in cryopreserved trophoblasts (upto 3 freezings and 10 passages). Activity of efflux transporters was confirmed in both placental primocultures and cryopreserved trophoblasts by an approximately 60% inhibition with cyclosporin A and valspodar for P-gp and 55% with elacridar for bcrp. In sum, this new in vitro model seems promising for a better Understanding of the role of P-gp and bcrp in the toxicity Of drugs during pregnancy and could be considered as an additional step towards the minimization of animal testing during drug development. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 34 条
[31]   Expression and transport activity of breast cancer resistance protein (BCRP/ABCG2) in dually perfused rat placenta and HRP-1 cell line [J].
Staud, Frantisek ;
Vackova, Zuzana ;
Pospechova, Katerina ;
Pavek, Petr ;
Ceckova, Martina ;
Libra, Antonin ;
Cygalova, Lenka ;
Nachtigal, Petr ;
Fendrich, Zdenek .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (01) :53-62
[32]   Efflux transporters of the human placenta [J].
Young, AM ;
Allen, CE ;
Audus, KL .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (01) :125-132
[33]   Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse [J].
Zhang, Yi ;
Wang, Honggang ;
Unadkat, Jashvant D. ;
Mao, Qingcheng .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) :2154-2158
[34]   The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: An obstetric-fetal pharmacology research unit network and University of Washington specialized center of research study [J].
Zhou, Lin ;
Naraharisetti, Suresh Babu ;
Wang, Honggang ;
Unadkat, Jashvant D. ;
Hebert, Mary F. ;
Mao, Qingcheng .
MOLECULAR PHARMACOLOGY, 2008, 73 (03) :949-959